GSK Reports Findings on Coadministered RSV and Shingles Vaccines
WEB1 day ago · Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody concentrations (immune response to Shingrix) and RSV-A and RSV-B neutralization titers increased from pre- …
Co-administration of Shingles and RSV Vaccines Produces …
WEB2 days ago · GSK plc recently announced topline Phase 3 clinical trial data for a combination regimen of two of its vaccines: the RSV vaccine Arexvy and Shingrix, a market-leading shingles shot. While GSK did not provide specific clinical trial (NCT05966090) data in its September 18, 2024 announcement, the company did confirm that co-administering Arexvy with Shingrix resulted in a “non-inferior immune ...
GSK's RSV, Shingles vaccines show on-par immune response in …
WEB4 days ago · The trial testing the immune response of co-administration of GSK's blockbuster vaccines, Shingrix and Arexvy, in adults over 50 years of age, met the main goal of the study. The co-administration ...
GSK Sees Positive Results in Trial of Combination RSV, Shingles …
WEB4 days ago · Resize. By Robb M. Stewart. GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and ...
Shingles vaccines may reduce dementia risk, two large new studies ... - CNN
WEBJul 30, 2024 · CNN — Two new studies suggest that getting a vaccine to protect against a painful case of shingles may be beneficial for memory, too. An estimated 98% of US adults have had chickenpox and are at...
Latest shingles vaccine may also delay dementia, study finds
WEBJul 26, 2024 · There may be new hope against dementia after recent research that found the latest shingles vaccine appears to delay the onset of the memory-impairing condition.
New shingles vaccine could reduce risk of dementia
WEBJul 25, 2024 · The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine. It is also more …
Shingles Vaccine Recommendations | Shingles (Herpes Zoster)
WEBJul 19, 2024 · CDC recommends Shingrix (recombinant zoster vaccine or RZV) for the prevention of herpes zoster (shingles) and related complications. This page summarizes CDC's current shingles vaccine recommendations.
Large study of shingles vaccine finds strong effectiveness over 4 …
WEBJan 8, 2024 · The vaccine currently used to protect people against shingles maintains strong effectiveness over 4 years post-vaccination, according to a Kaiser Permanente-led research study published in Annals of Internal Medicine.
Why You Should Get the Shingles Vaccine Soon | U.S. News
WEBNov 30, 2021 · Shingrix shingles vaccine is more than 90% effective in protecting healthy older adults from shingles and its painful side effects. Shingrix is the only approved shingles shot for U.S....